Letter from the President
Dear Royal Dames and Supporters,
How many of you have lost a loved one to cancer or have watched a dear friend or relative suffer through tortuous treatments as they battle the disease? The answer is far too many of you. This is at the heart of our mission. Since 1969 this charitable organization comprised of passionate women of Greater Fort Lauderdale has been raising funds dedicated to research efforts at the Rumbaugh-Goodwin Institute for Cancer Research at Nova Southeastern University. The institute conducts research on cancer diagnostics and powerful therapeutics for breast, lung, prostate, ovarian and colorectal cancers.
We have funded over $1 million of research instrumental in the discovery and development of new cancer drugs that have received US patent approval. One of the most exciting programs employs the GI-101 human tumor xenograft. RGI has patented a human tumor breast cancer xenograft that spontaneously metastasizes from a subcutaneous implant almost 100 percentof the time. The GI-101 human tumor xenograft models can be used to monitor the effects of anti- cancer and anti-metastatic drugs.
The patented F-16 compound, that we help fund, is now showing effectiveness equal to Taxol and better than some other anti-cancer drugs. RGI recently received two prestigious grants to advance studies in a new cancer treatment strategy using Phycocyanin, a compound extracted from bacteria that grows in our own Florida Everglades. It’s all very hopeful and exciting. This year RGI will make its new home in the state-of-the-future Center for Collaborative Research. Located on NSU’s main campus in Davie, Florida, the 215,000 square foot facility will feature an IBM supercomputer, one of Florida’s largest wet labs, and some of the world’s most accomplished researchers.
“Man is not destined to die of Cancer.” It is more than the motto of the Royal Dames. It has become the mantra for the researchers at RGI. Every Royal Dame and sponsor can take pride in their accomplishments. To be president of this organization is a privilege and I take this role very seriously, dedicating my time and effort to helping our organization continue the legacy of supporting meaningful efforts to treat and eradicate this disease.
Last year I was honored to chair our annual Tiara Ball. It was a huge success. Now we need your help to meet or exceed last year’s achievements. That is why we would like your attendance, sponsorship or both on November 12th, 2016 — our annual Tiara Ball where we’ll honor our own, Lorraine Thomas.
Rhonda Ritchie Aslaksen